Times Square Capital Management, LLC Royalty Pharma PLC Transaction History

Times Square Capital Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$29.6 - $36.56 $314,796 - $388,815	-10,635 Reduced 0.84%	1,257,195 $38.6 Million
Q1 2023 May 10, 2023	SELL	$32.77 - $39.4 $9.12 Million - $11 Million	-278,230 Reduced 18.0%	1,267,830 $45.7 Million
Q4 2022 Feb 10, 2023	SELL	$39.17 - $44.04 $737,962 - $829,713	-18,840 Reduced 1.2%	1,546,060 $61.1 Million
Q3 2022 Nov 09, 2022	SELL	$39.88 - $44.65 $1.71 Million - $1.92 Million	-42,900 Reduced 2.67%	1,564,900 $62.9 Million
Q2 2022 Aug 05, 2022	SELL	$37.53 - $44.22 $1.62 Million - $1.91 Million	-43,100 Reduced 2.61%	1,607,800 $67.6 Million
Q1 2022 May 06, 2022	SELL	$37.46 - $42.44 $93,650 - $106,100	-2,500 Reduced 0.15%	1,650,900 $64.3 Million
Q4 2021 Feb 04, 2022	BUY	$35.17 - $42.48 $4.69 Million - $5.67 Million	133,400 Added 8.78%	1,653,400 $65.9 Million
Q3 2021 Nov 08, 2021	BUY	$36.14 - $42.24 $666,421 - $778,905	18,440 Added 1.23%	1,520,000 $54.9 Million
Q2 2021 Aug 09, 2021	BUY	$39.85 - $46.63 $3.42 Million - $4.01 Million	85,945 Added 6.07%	1,501,560 $61.5 Million
Q1 2021 May 12, 2021	SELL	$42.34 - $52.82 $8.12 Million - $10.1 Million	-191,865 Reduced 11.94%	1,415,615 $61.7 Million
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $22.4 Million - $31 Million	618,970 Added 62.62%	1,607,480 $80.5 Million
Q3 2020 Nov 06, 2020	BUY	$38.56 - $48.36 $9.17 Million - $11.5 Million	237,710 Added 31.66%	988,510 $41.6 Million
Q2 2020 Aug 07, 2020	BUY	$44.5 - $52.11 $33.4 Million - $39.1 Million	750,800 New	750,800 $36.5 Million

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.